v3.26.1
Debt and Finance Leases (Tables)
 6 Months Ended
Jun. 27, 2026
Debt Disclosure [Abstract]  
Schedule of Long-term Debt Instruments
June 27, 2026December 31, 2025
ABL Credit Facility due November 2029: $76 million net availability and weighted average interest rate of 6.3% at June 27, 2026(a)
$36,250 $50,000 
2029 Term Loan due October 2029: interest rate of 11.2% at June 27, 2026
691,250 693,000 
5.50% CAD-based term loan due April 2028
18,268 18,923 
BioNova debt(b)
18,721 20,578 
Asset financing obligation17,025 — 
Other loans(c)
29,259 32,019 
Short-term factoring facility647 4,801 
Finance lease obligation211 456 
Total principal payments due811,631 819,777 
Less: unamortized premium, discount and issuance costs(36,858)(40,759)
Total debt$774,773 $779,018 
Debt due within one year$29,630 $20,909 
Long-term debt$745,143 $758,109 
(a)At June 27, 2026, the Company had $175 million of gross availability and net available borrowings of $76 million after taking into account the facility’s quarter end balance of $36 million, outstanding letters of credit of $37 million and required availability of $26 million to avoid triggering the facility’s fixed charge coverage ratio covenant.
(b)Consists of green loans associated with the France bioethanol plant, part of the net assets contributed by the Company to its subsidiary, BioNova.
(c)Consist of loans for energy projects in France.